跳至主要内容
临床试验/NCT04157075
NCT04157075已完成早期 1 期

The Effect of Intra-operative Uterosacral Bupivacaine Injection on Post-operative Pain in Patients Undergoing Minimally Invasive Hysterectomy

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2021年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
180
试验地点
2
主要终点
Difference in post-operative opioid usage with the use of uterosacral ligament bupivacaine injection

研究概览

简要总结

This is proof of concept, phase I randomized controlled trial studying a short acting non-opioid anesthetic, bupivacaine to improve post-operative pain in gynecologic surgery patients. Patients who are undergoing minimally invasive (laparoscopic or robotic) hysterectomy will be randomized to receive no uterosacral injection, normal saline uterosacral injection, or 0.25% bupivacaine uterosacral injection just prior to colpotomy (incision around the cervix and removal of uterus) during minimally invasive hysterectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Patients will be blinded to which arm they are in, surgeon will not as they will be performing injection however will not be assessing pain scores

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women over the age of 18 years old
  • undergoing benign minimally invasive hysterectomy with minimally invasive GYN surgeon at Johns Hopkins Hospital
  • Patients must be English speaking.

排除标准

  • Pregnancy
  • allergy, contraindication, or intolerance to bupivacaine, opioids, Tylenol, or NSAID drugs
  • pre-operative daily opioid consumption
  • peri-operative transverse abdominis plane block
  • recent history of drug or alcohol abuse (in last year)
  • severe cardiovascular, hepatic or renal disease.

研究组 & 干预措施

No injection

Placebo Comparator

No injection will be performed

干预措施: Bupivacaine (Drug)

Normal Saline Injection

Sham Comparator

Normal saline will be injected into the uterosacral ligaments prior to colpotomy

干预措施: Bupivacaine (Drug)

Bupivacaine Injection

Active Comparator

Bupivacaine will be injected into the uterosacral ligaments prior to colpotomy

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Difference in post-operative opioid usage with the use of uterosacral ligament bupivacaine injection

时间窗: 7 days post-op

Total morphine equivalents of opioids in the first 7 days after surgery will be assessed to look for a statistically significant difference

次要结局

  • Difference in Visual analog scores (VAS) scores following uterosacral ligament bupivicaine injection(7 days post-op)
  • Time to first bowel movement following uterosacral ligament bupivicaine injection(7 days post-op)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Intra-operative Uterosacral Ligament Bupivacaine... | 临床试验